Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo

Clinical trial NCT06694740 · RECRUITING

Trial details

NCT number: NCT06694740
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Post-aggressive Immunosuppression Adult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6 Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C

Start date: 2026-02-24
Primary completion: 2029-03-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.